您的位置: 首页 > 农业专利 > 详情页

Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated disease and conditions
专利权人:
Cayman Chemical Company; Inc.
发明人:
BARRETT, Stephen Douglas,CISKE, Fred Lawrence,COLOMBO, Joseph Michael,ENDRES, Gregory William,GERMAIN, Bradlee David,KOMILOV, Andriy,KRAMER, James Bernard,UZIEBLO, Adam,MAXEY, Kirk M.
申请号:
AU2017200044
公开号:
AU2017200044A1
申请日:
2017.01.04
申请国别(地区):
AU
年份:
2017
代理人:
摘要:
#$%^&*AU2017200044A120170202.pdf#####DIFLUOROLACTAM COMPOUNDS AS EP4 RECEPTOR-SELECTIVE AGONISTS FOR USE IN THE TREATMENT OF EP4-MEDIATED DISEASE AND CONDITIONS ABSTRACT Disclosed herein are compounds of formula (I) and therapeutic methods of treatment with compounds of formula (I), where Li, L2, L4, R4, R5, R6 and s are as defined in the specification. Compounds of formula (I) are EP4 agonists useful in the treatment of glaucoma, neuropathic pain, and related disorders. 1 0 F O N F L L SRG OH
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充